Latest / Bloomberg Intelligence / Apple Should Partner With Tesla On EVs: Wedbush's Ives
Transcript
- 0:01Speaker 1: Welcome to the Bloomberg Markets Podcast. I'm Paul Sweeney, along
- 0:04Speaker 1: with my co host of Bonnie Quinn. Every business day
- 0:06Speaker 1: we bring you interviews from CEOs, market pros, and Bloomberg experts,
- 0:10Speaker 1: along with essential market moving news. Find the Bloomberg Markets
- 0:13Speaker 1: Podcast on Apple podcast or wherever you listen to podcasts,
- 0:17Speaker 1: and on Bloomberg dot com. Apple is up two points
- 0:20Speaker 1: x percent today for the year, though year over year,
- 0:23Speaker 1: I should say from this day last year, Apple is
- 0:26Speaker 1: up eight So this two and a half percent increase
- 0:29Speaker 1: probably not the biggest of its year. Nevertheless, it's up
- 0:34Speaker 1: on an electric vehicle report. It's going to make one.
- 0:36Speaker 1: We knew it was going to, but now we have
- 0:38Speaker 1: a little bit more detail. So let's bring in somebody
- 0:40Speaker 1: who knows a lot about what Apple is doing and
- 0:42Speaker 1: how it can be successful done Eyes of web Bush
- 0:46Speaker 1: Securities joins so down. We knew that at some point
- 0:48Speaker 1: we would probably get an electric vehicle from Apple. What
- 0:52Speaker 1: do we know now that we didn't know in the
- 0:53Speaker 1: last few days. Well, I think it's really around the
- 0:56Speaker 1: battery technology and some of the innovations going on within Cupertino.
- 1:01Speaker 1: I mean, if you look at the e V and
- 1:03Speaker 1: the autonomous visioned Apple. There's been a lot of starts
- 1:07Speaker 1: and stops, but clearly they're going to dive into the
- 1:10Speaker 1: deep end of the pool. I believe it's going to
- 1:12Speaker 1: be through more of a strategic partnership where clearly it's
- 1:15Speaker 1: going to send a ripple effect across e VY and
- 1:18Speaker 1: from a stock perspective, it's just another arrow in the
- 1:22Speaker 1: quiver when you look at the overall ecosystem going forward,
- 1:27Speaker 1: Where does the confidence come from that Apple will be successful?
- 1:31Speaker 1: I mean it's it's great at other things, but I
- 1:33Speaker 1: mean vehicles are a whole different kettle fish. As they say, yeah,
- 1:38Speaker 1: no doubt, And that's why I don't believe that they
- 1:40Speaker 1: ultimately start manufacturing their own cars. I believe they're going
- 1:44Speaker 1: to leave that to a partner, potentially a Tesso or
- 1:47Speaker 1: v W because you know, I think that's the thing
- 1:51Speaker 1: investors want to see them, from a software perspective, vertically
- 1:54Speaker 1: integrate their software into vehicles. And I think if you
- 1:57Speaker 1: go out into the next few years, EVE, it's a
- 2:00Speaker 1: golden age and I think it's even similar what we're
- 2:03Speaker 1: seeing in China and Bay Do that they potentially you're
- 2:06Speaker 1: going to get into evs because we're talking about a
- 2:08Speaker 1: trillion dollar mark at the next decade, and the Apple
- 2:11Speaker 1: recognizes where they sit. Autonomous is key, and I think
- 2:16Speaker 1: this is just going to be another way for them
- 2:18Speaker 1: to monetize that you know, brand, which is unparalleled. Um,
- 2:22Speaker 1: this same argument is partially what's behind Tesla is nearly
- 2:25Speaker 1: seven h again this year, right while we're at three
- 2:29Speaker 1: percent or so ev take up right now, there will
- 2:32Speaker 1: be a point at which that becomes, you know, exponentially larger.
- 2:36Speaker 1: What about the idea of Apple teaming up with a Tesla,
- 2:38Speaker 1: is that something that would ever happened, Well, I think
- 2:43Speaker 1: they could potentially Apple and Tesla, and I think that's
- 2:46Speaker 1: a partnership that potentially could happen in terms of how
- 2:49Speaker 1: it fits strategically. So I think that could be somewhere
- 2:52Speaker 1: on the horizon two thousand one Musk and Cook on EVS.
- 2:57Speaker 1: That would be something that could have a ripple. In fact,
- 3:00Speaker 1: that's why I believe a test or VW is ultimately
- 3:03Speaker 1: who Apple partners with, right and essentially Apple needs to
- 3:09Speaker 1: find a partner. So what would be the best partner.
- 3:13Speaker 1: I'm the bed the best partners in stree mode in Tesla,
- 3:16Speaker 1: I think that's one that would make the most sense
- 3:18Speaker 1: strategically in terms of going after that market, especially where
- 3:22Speaker 1: e V is right now. I mean right now, in
- 3:24Speaker 1: terms of the e V market, it's Testa's world and
- 3:27Speaker 1: everyone else is paying rent. And that's something I can
- 3:30Speaker 1: see Apple further and further penetrating through a partnership. Down
- 3:35Speaker 1: talk to us about the rest of Apple's future. What's
- 3:37Speaker 1: your price target on Apple right now and what do
- 3:39Speaker 1: you see coming in the nearer future. Yeah, right now
- 3:43Speaker 1: we're a hundred sixty dollar price target two hundred bult case.
- 3:47Speaker 1: I continue to you as a supercycle iPhone twelve. I
- 3:50Speaker 1: think it's really just playing out in terms of China.
- 3:53Speaker 1: This is a key market, and to me, Apple is
- 3:57Speaker 1: a stock that I think invest is just further and
- 3:59Speaker 1: further appreciating in terms of what I'd view as an
- 4:02Speaker 1: unparalleled upgrade opportunity. That's why the super cycle pieces is
- 4:07Speaker 1: taken hold amazing. Then I also want to ask you
- 4:10Speaker 1: about the performance of Tesla on its first day in
- 4:13Speaker 1: the SMP five hundred and whether it adds to volatility.
- 4:16Speaker 1: So obviously we saw you know, run up and then
- 4:18Speaker 1: a little bit of a set off. What happens you know,
- 4:21Speaker 1: does it settle into regular SMP action. Yeah, I think
- 4:26Speaker 1: that was a bit of a sell in the news.
- 4:27Speaker 1: You know, obviously parabolic move into SMP five hundred inclusions.
- 4:32Speaker 1: It's really all about demand here. Demand looks very strong
- 4:36Speaker 1: in terms of December, especially in China. That's really the
- 4:40Speaker 1: winchman to move the stock higher. And that's why, you know,
- 4:43Speaker 1: we have a thousand hour bulk case on Tessa, and
- 4:46Speaker 1: I think it just comes down to execution in this
- 4:49Speaker 1: market you're seeing in China too, where it's only three
- 4:52Speaker 1: percent of all overall autos today, we think going to
- 4:55Speaker 1: ten percent untill two thousand twenty five. That's why right now,
- 4:58Speaker 1: e Z is you know, I think one of the
- 5:00Speaker 1: more transformational market opportunities we've seen in our last twenty years. Yeah. Well,
- 5:05Speaker 1: for sure of you watching that. I mean a lot
- 5:07Speaker 1: of people that that's that's all that coming are benefiting, right.
- 5:10Speaker 1: So I want to ask you as well about the
- 5:12Speaker 1: solar winds and the hat I mean the cybersecurity industry,
- 5:17Speaker 1: will is ultimately benefit it or hurt it. Well, for cybersecurity,
- 5:24Speaker 1: I think it could have three to five dips of
- 5:26Speaker 1: growth in the near term. I mean, this is what
- 5:29Speaker 1: likely looks like probably the biggest cyber security attack potentially
- 5:34Speaker 1: in the history and and and it's it's a black
- 5:36Speaker 1: eye for the overall for the industry, but the beneficiaries
- 5:42Speaker 1: are going to be massive. Because government agency is an enterprise,
- 5:45Speaker 1: they're gonna need to spend on companies like z Scale
- 5:49Speaker 1: or Tenable power Out, stail Point, among others. And that's
- 5:53Speaker 1: why you've seen these stocks continue move higher in terms
- 5:57Speaker 1: of where cybersecuit is going, especially in the shift to
- 5:59Speaker 1: claud Out. And this is you know, obviously this attack
- 6:02Speaker 1: just speaks of sophistication and threat, but that's a silver
- 6:07Speaker 1: lining in this very unfortunate incident. It's bullish for cybersecurity
- 6:12Speaker 1: stocks and investors are continuing to move those higher. What
- 6:16Speaker 1: are your topics in the space right now? Down the
- 6:19Speaker 1: topics and cybersecurity are Tenable, sail Point, z Scaler as
- 6:27Speaker 1: well as pal Out, So those are kind of names
- 6:29Speaker 1: front and center that I think benefit here. And we
- 6:32Speaker 1: believe cybersecurity stocked overall could be up more than between
- 6:38Speaker 1: now and the two thousand one. To me intact, taking
- 6:42Speaker 1: a step back, it's cloud cyber security and overall than
- 6:46Speaker 1: games led by Apple. That's the way to play this market. Amazing, Dum,
- 6:49Speaker 1: thank you so much for all of that, all of
- 6:51Speaker 1: your intelligence. Down Lives, Managing Director of Equity Research at
- 6:55Speaker 1: web Bush Securities. Well, it's pretty wild year for equity markets.
- 7:01Speaker 1: We're u S five hundred, but we really, I mean
- 7:05Speaker 1: we dropped into you bear market territory more than that.
- 7:09Speaker 1: In fact, we were down about thirty something percent at
- 7:11Speaker 1: one point in March. It's been even wilder year for treasuries.
- 7:15Speaker 1: We went from you know, one point nine something percent
- 7:19Speaker 1: right down to fifty basis points and we've retraced a
- 7:22Speaker 1: little bit of that now. So let's bring in somebody
- 7:25Speaker 1: you have to advise clients through this whole volatility. Lisa
- 7:28Speaker 1: Charlotte is the chief investment officer for wealth management at
- 7:31Speaker 1: Morgan Stanley about two and a half trillion dollars in
- 7:33Speaker 1: client assets. Lisa, how are you feeling as we approach
- 7:37Speaker 1: the end of twenty twenty So, um, look, we're feeling
- 7:42Speaker 1: um bullish. Uh, clearly, you know we believe that that um,
- 7:47Speaker 1: we're in a v shaped recovery. Although it's unfortunate that
- 7:52Speaker 1: you know, we're currently experiencing this this latest surge in
- 7:56Speaker 1: the virus um, we are constructive that potential it will
- 8:00Speaker 1: be the last such surge. Um. You know, as we
- 8:04Speaker 1: get through the months of the tough months of January
- 8:07Speaker 1: and February and and get larger portions of the population vaccinated.
- 8:13Speaker 1: But the momentum, the underlying momentum in the economy continues
- 8:18Speaker 1: to be very solid. I think, you know, some of
- 8:21Speaker 1: the backward looking data that we've gotten over the last
- 8:23Speaker 1: eight weeks, you know, showed that there was slowing in
- 8:27Speaker 1: November and December. We could as you noted, that the
- 8:29Speaker 1: consumer confidence numbers fell more than expected. But uh, you know,
- 8:34Speaker 1: the past is the Finally, the passage of this fiscal
- 8:38Speaker 1: stimulus spell should put a floor underneath confidence. And that
- 8:43Speaker 1: combined with with um, you know, the vaccine should should
- 8:47Speaker 1: be able to to bridge us to to uh a
- 8:50Speaker 1: full recovery by the middle of next year. And and
- 8:53Speaker 1: you know, we think markets can kind of get uh
- 8:57Speaker 1: huh so more to go. Obviously, you're you said your bullish.
- 9:00Speaker 1: I mean, if you had stayed in the market, if
- 9:02Speaker 1: you had kept your nerves this whole time, you'd be
- 9:04Speaker 1: quite happy. But now I wonder what's priced in lison,
- 9:08Speaker 1: what's left to price and surely some of that good
- 9:10Speaker 1: news is already priced. Yeah. Look, I think that the
- 9:14Speaker 1: reason markets have stalled out here at the end of
- 9:17Speaker 1: the year is in part, uh, not just about you know,
- 9:22Speaker 1: sentiment about the virus itself, but it's about the fact
- 9:26Speaker 1: that we don't have a lot of more positive catalysts
- 9:30Speaker 1: to go. This is a market that has priced an
- 9:32Speaker 1: extraordinary amount of what has proven to be upside surprises, right,
- 9:38Speaker 1: whether we're talking about the speed of recovery, whether we're
- 9:42Speaker 1: talking about the fact that retail sales have held up,
- 9:45Speaker 1: whether we're talking about the fact that consumer balance sheets
- 9:49Speaker 1: have not deteriorated, credit card chart drops or not skyrocketing,
- 9:54Speaker 1: bankruptcies are not sky rocketing. The stimulus measures, uh, you
- 9:59Speaker 1: know thus far appear to have worked. Um. And you know,
- 10:03Speaker 1: we are looking at uh consensus forecast for corporate profits
- 10:10Speaker 1: next year to actually be up year over year about
- 10:14Speaker 1: pent So, uh, that's a lot of good news. And
- 10:17Speaker 1: that's certainly what you know, a price earning ordered price
- 10:20Speaker 1: earnings ratio of of twenty two times tells you I
- 10:24Speaker 1: and so this is a market that's going to have
- 10:25Speaker 1: to digest and and let a little bit of main
- 10:29Speaker 1: street and reality and the numbers catch up to the anticipation.
- 10:34Speaker 1: But you know, we think that next year, UM, you know,
- 10:37Speaker 1: stocks uh, at least as measured by the index, you know,
- 10:41Speaker 1: can be up another you know, five seven percent for
- 10:44Speaker 1: those deliance however that need you know something more than
- 10:48Speaker 1: that that are looking for ten percent or fifteen. What
- 10:52Speaker 1: we've said is you've got to look at individual stocks.
- 10:55Speaker 1: You've got to look outside the US. You've got to
- 10:57Speaker 1: look in small and mid caps, uh, because the index
- 11:01Speaker 1: itself is really pretty rich. What about stocks that had
- 11:06Speaker 1: been overlooked, such as financials where we saw a massive
- 11:10Speaker 1: rally yesterday a Goldman, Zachs, Take Morgan and so on
- 11:12Speaker 1: after the buybacks and dividends news. They're you know, undervalued
- 11:17Speaker 1: according to some value investors right now. So our surgeon,
- 11:20Speaker 1: areas of healthcare, anything in those areas attract to you, Lisa,
- 11:26Speaker 1: absolutely so. Our our number one idea for is financials. Uh.
- 11:32Speaker 1: You know, we published our report this week, you know,
- 11:35Speaker 1: talking about the fact that, um, not only do we
- 11:38Speaker 1: think that the yield curve does steepen next year, which
- 11:42Speaker 1: will help with net interest income, but we do think
- 11:46Speaker 1: that the charge offs this cycle loan losses are going
- 11:50Speaker 1: to be significantly less than historical and therefore a lot
- 11:54Speaker 1: of the reserves that were taken by the banks will
- 11:57Speaker 1: be released back into currenting. Obviously. Uh, you know, we've
- 12:03Speaker 1: gotten a little bit of regulatory forbearance here and and
- 12:06Speaker 1: you know we saw that as he said, with the
- 12:09Speaker 1: FED allowing the resumption of of of share buy backs.
- 12:14Speaker 1: That's going to help the factor. And look, last, last,
- 12:17Speaker 1: but not least, is there are lasting behavioral changes that
- 12:23Speaker 1: that occurred during this pandemic that we believe create huge
- 12:29Speaker 1: profit opportunities and efficiencies for the bank. Well, Lisa, we
- 12:33Speaker 1: are going to have to get into those behavioral changes
- 12:36Speaker 1: another time, but we really really appreciated looking forward to
- 12:38Speaker 1: that particular conversation and happy holidays to you. Much appreciate.
- 12:42Speaker 1: That's Lisa Shallows of Morgan Standie Wealth Management. Let's bring
- 12:47Speaker 1: in something else now. David Garrity is with us, his
- 12:50Speaker 1: chief market strategists for laid Law and Company also partner
- 12:53Speaker 1: at bt Block, a cybersecurity and blockchain firm. And we've
- 12:57Speaker 1: got the laid Law five forecasts for one, so David
- 13:01Speaker 1: gets straight into it. What's your five forecast for next year? Yeah,
- 13:06Speaker 1: the five forecasts are starting off bunny, looking at the
- 13:09Speaker 1: fact that the market is still very much dependent upon
- 13:13Speaker 1: government fiscal stimulus, whether it's here in the US or
- 13:15Speaker 1: whether it's coming from overseas um. You know, from that standpoint,
- 13:20Speaker 1: we think that the markets will start the year off choppy,
- 13:23Speaker 1: with games going more towards the back half of the year.
- 13:26Speaker 1: Talking about markets, we have an objective for the S
- 13:30Speaker 1: and P five hundreds of four thousand for two thou one,
- 13:35Speaker 1: about eight percent upside, and we think that against this backdrop,
- 13:39Speaker 1: we're going to have interest rates rise on the ten
- 13:42Speaker 1: ure to about one and a half percent. Obviously, we
- 13:45Speaker 1: think inflation is gonna run hot, break evens going from
- 13:48Speaker 1: one to two point three. And then against that backdrop,
- 13:52Speaker 1: we're going to have the dollar weekend against foreign currencies
- 13:55Speaker 1: by ten, you know, off the strength of better economic
- 14:00Speaker 1: growth forecasts outside the US then the US. We're calling
- 14:03Speaker 1: for international stocks non US to appperform over the course
- 14:08Speaker 1: of one and we think that here within the US,
- 14:11Speaker 1: with an economic reopening value sectors are actually going to
- 14:15Speaker 1: perform tech in the year ahead, although tech will continue
- 14:19Speaker 1: to have growth from disrupting as it does. Yeah, fascinating.
- 14:23Speaker 1: So that's a really complex look at the markets. Is
- 14:26Speaker 1: that one forecast. I just want to make sure David
- 14:28Speaker 1: or all five. Um, that's all five sort of wrapped
- 14:32Speaker 1: into one statement. Well, talk to us that about the
- 14:36Speaker 1: and I'll get to that at the end. Talk to
- 14:39Speaker 1: us about the value plays. Because we were speaking earlier
- 14:41Speaker 1: to somebody who thought that financial stocks and some areas
- 14:44Speaker 1: of healthcare might be the places to look for free,
- 14:47Speaker 1: fresh value. Where are you seeing that? Yeah, and I
- 14:50Speaker 1: certainly would agree. Relative to financials and the fact that
- 14:54Speaker 1: you know, central banks are allowing the financials to go
- 14:57Speaker 1: engage in buy backs, namely the federal reserves, and now
- 15:00Speaker 1: it's been in the impact that will have in the
- 15:01Speaker 1: lights of the JP Morgan as well as Goldman, Sacks
- 15:04Speaker 1: and others certainly favors the financials. Clearly, it's the steepening
- 15:07Speaker 1: yield curve which is a thing that really will serve
- 15:10Speaker 1: to drive the financials. We think also at the same
- 15:13Speaker 1: time that a recovering oil price going from forty dollars
- 15:17Speaker 1: a barrel now backed up towards sixty over the course
- 15:20Speaker 1: of one will certainly prove to support what has been
- 15:23Speaker 1: one of the weakest sectors this year, which has been energy.
- 15:26Speaker 1: You know, down about or so in under formed the
- 15:30Speaker 1: s and p f UM. You know, so we think
- 15:34Speaker 1: that energy really is going to be probably the leading
- 15:36Speaker 1: recovery trade. But along with that, we'd also would throw
- 15:39Speaker 1: in with the financials with energy also looking at industrial
- 15:42Speaker 1: stocks industrials. Interesting, what area of industrialism would that be
- 15:47Speaker 1: dedicated on some kind of an infrastructure package. It may
- 15:51Speaker 1: be very much driven by an infrastructure package. Certainly have
- 15:53Speaker 1: seen positive performance coming out of the likes of Caterpillar
- 15:57Speaker 1: UM so far here in the fourth quarter of We
- 16:00Speaker 1: think that there's further upside relative to that. We certainly
- 16:03Speaker 1: think that you know, the ground is that uh in
- 16:07Speaker 1: the US to see a good infrastructure program being put
- 16:10Speaker 1: in place. Hopefully Congress cooperates, but that's what's going to
- 16:14Speaker 1: give people, we think in the markets preps someone on
- 16:17Speaker 1: hold until we get a better idea as to whether
- 16:20Speaker 1: we're really going to become bipartisan in one and not
- 16:24Speaker 1: necessarily as partisan as we've been. David, I want to
- 16:28Speaker 1: ask you a little bit about cybersecurity as well. Bt
- 16:32Speaker 1: block is a place where your partner and it's a
- 16:35Speaker 1: cybersecurity intelligence and a blockchain firm. I'm not sure how
- 16:38Speaker 1: related the two are, but certainly we've had this massive,
- 16:42Speaker 1: massive cybersecurity breach. It's very very serious and it goes
- 16:46Speaker 1: back as far as six months maybe more, to places
- 16:49Speaker 1: like Treasury and other agencies. How do you see this
- 16:52Speaker 1: playing out or are we in endanger that right now
- 16:56Speaker 1: without even realizing it, into the extent of foll have
- 17:00Speaker 1: gone more and more online over the course of has
- 17:03Speaker 1: worked from home became the new normal and is likely
- 17:06Speaker 1: to extend into uh, you know, the fact that people
- 17:10Speaker 1: having information observed or leaked certainly grows. And from the standpoint,
- 17:16Speaker 1: what we've been doing within DT block have been you know,
- 17:18Speaker 1: developing improved ways of managing passwords. One of the things
- 17:22Speaker 1: that was the major weakness within Solar Winds was that
- 17:26Speaker 1: they really hadn't practiced anything near decent password management discipline,
- 17:32Speaker 1: and that's what created the the open window, if you will,
- 17:36Speaker 1: that others were we're able to come in from, especially
- 17:39Speaker 1: from Russia, will be able to find a fix or
- 17:43Speaker 1: a patch or whatever you do find for this. I mean,
- 17:45Speaker 1: it sounds like it's gone so viral that we're talking
- 17:48Speaker 1: about you know, x number of Fortune copies, X number
- 17:51Speaker 1: of US agencies and governmental departments and so on, how
- 17:55Speaker 1: do you patch that up? Yeah, I mean the issue
- 17:58Speaker 1: that you had with solar winds, the hack was that
- 18:01Speaker 1: there was essentially code that was put into software updates
- 18:05Speaker 1: if they were sending out to all their installed clients,
- 18:07Speaker 1: both government agencies as well as also private sector entities,
- 18:11Speaker 1: and you know, that's how the backdoor basically got populated
- 18:15Speaker 1: across the user base. Now, the problem you're going to
- 18:18Speaker 1: have here and trying to remedy this problem is that
- 18:20Speaker 1: the backdoor that was put in wasn't necessarily the only one.
- 18:23Speaker 1: Um you know, there are also other additional means of
- 18:27Speaker 1: establishing backdoors in the various systems that have been populated
- 18:30Speaker 1: as a result of this act. So trying to find
- 18:32Speaker 1: a way to actually go through and clean it up
- 18:35Speaker 1: is going to take some extended period of time. Relative
- 18:40Speaker 1: to government policy, you know, there clearly is an opportunity
- 18:43Speaker 1: and in need here on the policy front to basically
- 18:47Speaker 1: become or unified as regards cybersecurity how it's practiced, not
- 18:51Speaker 1: just within the government but across the US as a whole. David,
- 18:55Speaker 1: if there are some stocks in that area that you
- 18:57Speaker 1: would recommend, would be very grateful not just to cybersecurity,
- 19:00Speaker 1: but also blockchain. Um. You know, in terms of looking
- 19:04Speaker 1: at blockchain, there have been a number of vehicles we
- 19:07Speaker 1: think that you know, our Investment Management has had a
- 19:09Speaker 1: blockchain ETF that's out there that's very good in terms
- 19:13Speaker 1: of highlighting some of the stronger names. Our Investment Management
- 19:16Speaker 1: through their disruption UH or innovation ETF you know, had
- 19:21Speaker 1: a bannery year of a hundred and fifty two m.
- 19:24Speaker 1: Granted it might have been more due to Tesla in
- 19:26Speaker 1: terms of their vehicles, but you know, I think over
- 19:29Speaker 1: the course of emerging there will be more names that
- 19:32Speaker 1: will be looking at and be happy to highlight at
- 19:34Speaker 1: that time. Great well, David, thanks so much for joining
- 19:38Speaker 1: us today, and have a wonderful rest of your year.
- 19:41Speaker 1: David Garity is chief market strologist at laid Law and Company,
- 19:44Speaker 1: also partner at bat Block of Cybersecurity, Intelligence and blockchain firm.
- 19:49Speaker 1: On there to talk about is laid Law five. Those
- 19:51Speaker 1: forecasts for one hospitals are deluged in the United States
- 19:57Speaker 1: and places such as California. I see you capacity is
- 20:00Speaker 1: down to less than two and a half percent right now,
- 20:02Speaker 1: and of course fatalities are climbing. Let's bring in some Fazali,
- 20:07Speaker 1: Senior farm analyst and head of e m A Research
- 20:09Speaker 1: at Bloomberg Intelligence. To talk about this obviously, as well
- 20:12Speaker 1: as the vaccines and this variant that we're seeing in
- 20:15Speaker 1: the United Kingdom that may already be in Germany and
- 20:18Speaker 1: France some how important is a distress that this is
- 20:21Speaker 1: a variant and not a new strain. Oh, hi, Vannie,
- 20:26Speaker 1: So I mean, look, it's it's nomenclature, scientific nomenclature. I
- 20:31Speaker 1: mean a strain Star two is a new strain of
- 20:34Speaker 1: the coronavirus versus Stars kobe us. So it's just it's
- 20:39Speaker 1: just to be to be pedantic. It's the right it's
- 20:41Speaker 1: the right way to put it. This is a variant
- 20:43Speaker 1: because it's the same family. Still, does it mean that
- 20:48Speaker 1: the current vaccines will also work against it? Or do
- 20:51Speaker 1: we know that yet? So we don't know for sure.
- 20:55Speaker 1: There are lots of reasons to remain optimistic the vaccines
- 20:59Speaker 1: will be Apparently, at least the fires A BioNTech one.
- 21:04Speaker 1: The immune response they've seen to it does not seem
- 21:08Speaker 1: to correlate with the areas where the mutations are, but
- 21:12Speaker 1: mutations can also change the shape of this. The confirmation,
- 21:17Speaker 1: if you like, of the spike protein which is being
- 21:20Speaker 1: targeted by the vaccines, so it might diminish the efficacy,
- 21:24Speaker 1: but luckily we're starting at efficacy, so it's going to
- 21:29Speaker 1: be quite good to see what that might be. Even
- 21:33Speaker 1: if it's is still a pretty pretty serious help in
- 21:37Speaker 1: managing the pandemic. Now, this particular variant, we know that
- 21:41Speaker 1: it's more contagious. Do we know how people are reacting
- 21:44Speaker 1: when they get it? Is it the same type of reactions?
- 21:46Speaker 1: Are they as sick? You know, our ventilator is something
- 21:50Speaker 1: that did come up. It's too early to tell, you know,
- 21:54Speaker 1: the the the the only way we know is in
- 21:57Speaker 1: a few weeks time as hospitalizations mortality data come through
- 22:02Speaker 1: and then you can see what what what variant of
- 22:05Speaker 1: the virus was was causing those issues. You need the
- 22:09Speaker 1: data to be able to tell, and just by looking
- 22:12Speaker 1: at the numbers it's impossible to be able to tell because,
- 22:14Speaker 1: as you rightly said, if the ice use are jam packed,
- 22:18Speaker 1: then people's mortality is likely to go up because they
- 22:20Speaker 1: can't deal with them better. So that's that's Those are
- 22:23Speaker 1: key elements that that some serious science needs to be
- 22:26Speaker 1: done to figure it out. The measure is being taken,
- 22:29Speaker 1: so lockdown and various countries restricting travel into their countries
- 22:34Speaker 1: from the United Kingdom for various amounts of time, and
- 22:37Speaker 1: those may get extended. Is that the right thing to do?
- 22:42Speaker 1: They It's possible that it's that it's a bit late
- 22:47Speaker 1: in terms of shutting the stable doors after the horse
- 22:51Speaker 1: has already bolted, And it's possible that they already that
- 22:55Speaker 1: they that the virus has evolved the same mutations in
- 22:59Speaker 1: you know, we've seniored already in South Africa, very similar
- 23:02Speaker 1: mutation is not identical, but to very similar mutations in
- 23:06Speaker 1: other countries. And I would be amazed if it's not
- 23:09Speaker 1: already in the United States. So that's the key thing here.
- 23:14Speaker 1: I'm going to repeat that Sam Fazali, who is head
- 23:16Speaker 1: of our pharma analytics and really has been on top
- 23:20Speaker 1: of everything coronavirus related, understands it all, says that he
- 23:24Speaker 1: would be amazed if this new variant is not already
- 23:26Speaker 1: in the United States, a variant that is more contagious some.
- 23:30Speaker 1: The longer that this you know, COVID nineteen plus its
- 23:36Speaker 1: variants get to linger in a country and in the world,
- 23:39Speaker 1: the more mutations will have. Right, How isn't it getting
- 23:43Speaker 1: more and more serious and more and more urgent that
- 23:47Speaker 1: you know, we impose draconian measures to try and stop
- 23:51Speaker 1: this thing. Well, I kind of wrote that back in
- 23:54Speaker 1: if you remember Vannie back here a couple of months ago,
- 23:57Speaker 1: as the US cases were starting to rise. The issue
- 24:01Speaker 1: is that the more the virus, as you rightly say,
- 24:03Speaker 1: the more the virus mutass, the more people have got
- 24:06Speaker 1: this virus, the more opportunity gets to me to sorry,
- 24:10Speaker 1: the more opportunity gets to mutate, and that obviously eventually
- 24:14Speaker 1: it finds ways around our immune system. So the key
- 24:18Speaker 1: thing is to really try and bring it down to
- 24:21Speaker 1: levels that a lot of Europe. You know, in France,
- 24:23Speaker 1: if you look at the case numbers, they've managed to
- 24:25Speaker 1: bring it down quite meaningfully, although they've just relaxed a
- 24:28Speaker 1: little bit their rules. And I'm worried that cases will
- 24:31Speaker 1: start rising again. So that that's the element. And Drew
- 24:34Speaker 1: Conian or not, I mean, you've seen the effect you
- 24:37Speaker 1: can have on a country if they don't if they
- 24:40Speaker 1: don't make the right decisions. But what's going on in
- 24:42Speaker 1: the UK. Yeah, so some we are seeing vaccines rollout today.
- 24:47Speaker 1: Fauci and friends got the MODERNA vaccine. We had already
- 24:51Speaker 1: seen other officials get the Visor vaccine. I guess you know,
- 24:56Speaker 1: when we eventually are able to get a vaccine, doesn't
- 24:58Speaker 1: matter which one we receive. Oh, they are very lucky people, actually,
- 25:04Speaker 1: I mean I don't care which one I get. If
- 25:06Speaker 1: if whatever one's available between Maderna and finds my on take,
- 25:09Speaker 1: I would happily take it. It's um, they're pretty similar.
- 25:12Speaker 1: One's got maybe a little bit less a little a
- 25:15Speaker 1: little bit more troublesome than the other, but frankly it's
- 25:18Speaker 1: neither here nor there. So I'm just jealous of them
- 25:21Speaker 1: getting it. So do you have any concerns at all
- 25:24Speaker 1: about the idea that there may have been extra doses
- 25:26Speaker 1: that Fiser wasn't willing to sort of allow. It was
- 25:30Speaker 1: putting a little extra into vials just to allow for
- 25:33Speaker 1: you know, maybe a little bit of spillage or what
- 25:35Speaker 1: have you. But hospitals are now seeing that, you know,
- 25:38Speaker 1: they can be made into extra doses and maybe even
- 25:40Speaker 1: a dozen and a half. Does that concern you at all?
- 25:43Speaker 1: Should these administrators be confined to just five doses per vile? No,
- 25:50Speaker 1: it doesn't. It doesn't concern me at all. I mean,
- 25:53Speaker 1: you know this, you're activating the immune system here. Even
- 25:56Speaker 1: if you get twenty five micrograms or thirty five micrograms,
- 25:58Speaker 1: and please, I am hyph pothesizing here, right, it probably
- 26:01Speaker 1: doesn't make that much difference um in terms of the
- 26:05Speaker 1: kind of immune reaction that it causes. So the important
- 26:09Speaker 1: thing is that, you know, the more doses we have,
- 26:11Speaker 1: the better. I am, however, not a fan of what
- 26:15Speaker 1: a lot of people seem to be talking about, which is,
- 26:18Speaker 1: let's just do one does because it showed some efficacy
- 26:20Speaker 1: after one does, and then we can extend this out.
- 26:23Speaker 1: We have no idea what it does after one dose.
- 26:26Speaker 1: It was just part of a trial where the endpoint
- 26:29Speaker 1: of the trial was a two dose trial. You can't
- 26:32Speaker 1: make these decisions based on what anecdotal evidence one trial
- 26:36Speaker 1: shows you what So that that that's a big concern
- 26:39Speaker 1: for me. These interviews are always full of public health announcements,
- 26:42Speaker 1: and there is another one. Don't just take one does
- 26:44Speaker 1: if you're lucky enough to be in the system, go
- 26:46Speaker 1: back for your second dos because you don't know what
- 26:48Speaker 1: you're in for if you just take the one. But
- 26:49Speaker 1: you do know how lucky you are if you happen
- 26:52Speaker 1: to get to some how long will it be before
- 26:54Speaker 1: we know if there are any adverse effects and the
- 26:56Speaker 1: population in general that are vaccinated. We so I just
- 27:00Speaker 1: put a update ut today on our BI platform looking
- 27:05Speaker 1: at the data that we've seen already. If the numbers
- 27:08Speaker 1: are right, CDC has reported six allergic reactions by Friday night,
- 27:12Speaker 1: and I estimate about five hundred thousand people have been
- 27:15Speaker 1: vaccinated in the US. So that's a case rate of
- 27:18Speaker 1: not point not not one to percent. I mean, it's
- 27:21Speaker 1: let's put it this way, it's a very small percentage
- 27:24Speaker 1: of people. Of course, if one person getting a side
- 27:27Speaker 1: effect is not a good thing. But this seems to
- 27:29Speaker 1: be manageable. And we'll have to wait till January February
- 27:33Speaker 1: to hear about Bell's palsy because that takes a little
- 27:36Speaker 1: while longer at least in the trials to surface. So
- 27:40Speaker 1: let's see how that shows up. Some thank you so much,
- 27:44Speaker 1: and thank you for all of your hard work all
- 27:46Speaker 1: year keeping an eye and everything coronavirus related for us
- 27:49Speaker 1: being much much appreciated. That is some for sale who
- 27:52Speaker 1: has head of E M. E. A Research as Bloomberg
- 27:54Speaker 1: Intelligence but also senior pharmer analyst. Thanks for listening to
- 27:59Speaker 1: Bloomberg Markets podcast. You can subscribe and listen to interviews
- 28:03Speaker 1: at Apple Podcasts or whatever a podcast platform you prefer.
- 28:06Speaker 1: I'm Bonnie Quinn, I'm on Twitter at Bonnie Quinn. And
- 28:09Speaker 1: I'm Paul Sweeney. I'm on Twitter at pt Sweeney. Before
- 28:12Speaker 1: the podcast, you can always catch us worldwide at Bloomberg
- 28:15Speaker 1: Radio